◀ Back to RELA
CDKN2A — RELA
Text-mined interactions from Literome
Guo et al., Mol Cell Biol 2004
:
We found that ( i ) p19(Arf) or p53 deficiency led to a significant increase in PI 3-kinase activity, which in turn upregulated RhoA and Rac1 activities ; ( ii ) deletion of p19Arf or p53 led to an increase in cell growth rate that was in part dependent on RhoA, Rac1, and Cdc42 activities ; ( iii
) p19(Arf) or p53 deficiency
caused an enhancement of the growth related transcription factor
NF-kappa B and cyclin D1 activities that are partly dependent on RhoA or Cdc42 but not on Rac1 ; ( iv ) forced expression of the activating mutants of Rac1, RhoA, or Cdc42 caused a hyperproliferative phenotype of the p19Arf ( -/- ) and p53 ( -/- ) cells and promoted transformation of both cells ; ( v ) RhoA appeared to contribute to p53 regulated cell proliferation by modulating cell cycle machinery, while hyperactivation of RhoA further suppressed a p53 independent apoptotic signal ; and ( vi ) multiple pathways regulated by RhoA, including that of Rho-kinase, were required for RhoA to fully promote the transformation of p53 ( -/- ) cells
Becker et al., Biochem Biophys Res Commun 2005
(Melanoma) :
p16INK4a binding and
inhibition of the transcription factor
NF-kappaB has been shown and is consistent with the reports of abnormally increased NF-kappaB activity in various cancers including melanoma ... Furthermore, whereas wild type
p16INK4a strongly
inhibits NF-kappaB transcriptional activity, a subset of melanoma associated p16INK4a mutants show reduced NF-kappaB inhibitory function ...
p16INK4a does not
affect NF-kappaB nuclear translocation or DNA binding, suggesting a mechanism that reduces NF-kappaB transactivation activity